Materials & Resources » Mining, Metals & Minerals | RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.
Stock Exchange Other OTC
EPS
$0.1
Market Cap
$6.02 M
Shares Outstanding
21.44 M
Public Float
20.19 M
RepliCel Life Sciences Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
21.44 M
Public Float
20.19 M
RepliCel Life Sciences Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.13
Market Cap
CAD7.86 M
Shares Outstanding
17.25 M
Public Float
8.62 M

Profile

Address
570 Granville Street
Vancouver British Columbia V6C 3P1
Canada
Employees -
Website http://www.replicel.com
Updated 07/08/2019
RepliCel Life Sciences, Inc. is a regenerative medicine company, which focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.

Financials

View All

David M. Hall
Chairman
Robert Lee Buckler
President, CEO, Secretary & Director